Apply for funding to study why people respond differently to biomedical prevention interventions. Projects must generate mechanistic evidence in humans to provide insight into precision prevention through better targeting.
You must be based at a UK research organisation eligible for MRC funding.
Apply to the MRC Impact Acceleration Award to address a single, high-risk development step and generate key data to de-risk a new medicine, medical device, diagnostic or other medical product.
You must be based at a research organisation eligible for MRC funding.
UK registered organisations can apply for a share of up to £33 million to develop device level hardware and associated software to meet the scale, programmability, and runtime performance needs of universal fault tolerant quantum computers.
UK registered organisations can apply for a share of up to £150 million, to create scale up manufacturing facilities for zero emission vehicle technologies.
UK registered businesses can apply for a share of up to £3 million for innovative projects in specific technology areas. You must collaborate with at least one Swiss implementation partner applying under the equivalent Swiss Innosuisse programme.